These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 26985652)

  • 41. Conjugation of curcumin onto alginate enhances aqueous solubility and stability of curcumin.
    Dey S; Sreenivasan K
    Carbohydr Polym; 2014 Jan; 99():499-507. PubMed ID: 24274536
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Preparation and enhancement of oral bioavailability of curcumin using microemulsions vehicle.
    Hu L; Jia Y; Niu F; Jia Z; Yang X; Jiao K
    J Agric Food Chem; 2012 Jul; 60(29):7137-41. PubMed ID: 22587560
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Inhibition of nitrite induced oxidation of hemoglobin by curcuminoids.
    Unnikrishnan MK; Rao MN
    Pharmazie; 1995 Jul; 50(7):490-2. PubMed ID: 7675894
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Recent developments in curcumin and curcumin based polymeric materials for biomedical applications: A review.
    Mahmood K; Zia KM; Zuber M; Salman M; Anjum MN
    Int J Biol Macromol; 2015 Nov; 81():877-90. PubMed ID: 26391597
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Physico-chemical state influences in vitro release profile of curcumin from pectin beads.
    Nguyen AT; Winckler P; Loison P; Wache Y; Chambin O
    Colloids Surf B Biointerfaces; 2014 Sep; 121():290-8. PubMed ID: 25009104
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Phase behavior and oral bioavailability of amorphous Curcumin.
    Pawar YB; Shete G; Popat D; Bansal AK
    Eur J Pharm Sci; 2012 Aug; 47(1):56-64. PubMed ID: 22609283
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of curcumin on LDL oxidation in vitro, and lipid peroxidation and antioxidant enzymes in cholesterol fed rabbits.
    Mahfouz MM; Zhou Q; Kummerow FA
    Int J Vitam Nutr Res; 2011 Nov; 81(6):378-91. PubMed ID: 22673922
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Preparation and characterization of water-soluble albumin-bound curcumin nanoparticles with improved antitumor activity.
    Kim TH; Jiang HH; Youn YS; Park CW; Tak KK; Lee S; Kim H; Jon S; Chen X; Lee KC
    Int J Pharm; 2011 Jan; 403(1-2):285-91. PubMed ID: 21035530
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Curcumin derivatives as new ligands of Aβ peptides.
    Airoldi C; Zona C; Sironi E; Colombo L; Messa M; Aurilia D; Gregori M; Masserini M; Salmona M; Nicotra F; La Ferla B
    J Biotechnol; 2011 Dec; 156(4):317-24. PubMed ID: 21807037
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Temperature-dependent spectroscopic evidences of curcumin in aqueous medium: a mechanistic study of its solubility and stability.
    Jagannathan R; Abraham PM; Poddar P
    J Phys Chem B; 2012 Dec; 116(50):14533-40. PubMed ID: 23194397
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Enhanced dispersibility and bioactivity of curcumin by encapsulation in casein nanocapsules.
    Pan K; Zhong Q; Baek SJ
    J Agric Food Chem; 2013 Jun; 61(25):6036-43. PubMed ID: 23734864
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Recent advances in curcumin nanoformulation for cancer therapy.
    Lee WH; Loo CY; Young PM; Traini D; Mason RS; Rohanizadeh R
    Expert Opin Drug Deliv; 2014 Aug; 11(8):1183-201. PubMed ID: 24857605
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Immunoliposome encapsulation increases cytotoxic activity and selectivity of curcumin and resveratrol against HER2 overexpressing human breast cancer cells.
    Catania A; Barrajón-Catalán E; Nicolosi S; Cicirata F; Micol V
    Breast Cancer Res Treat; 2013 Aug; 141(1):55-65. PubMed ID: 23959397
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Curcumin phytosomal softgel formulation: Development, optimization and physicochemical characterization.
    Allam AN; Komeil IA; Abdallah OY
    Acta Pharm; 2015 Sep; 65(3):285-97. PubMed ID: 26431106
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Redox nanoparticles inhibit curcumin oxidative degradation and enhance its therapeutic effect on prostate cancer.
    Thangavel S; Yoshitomi T; Sakharkar MK; Nagasaki Y
    J Control Release; 2015 Jul; 209():110-9. PubMed ID: 25912409
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Curcumin conjugated silica nanoparticles for improving bioavailability and its anticancer applications.
    Gangwar RK; Tomar GB; Dhumale VA; Zinjarde S; Sharma RB; Datar S
    J Agric Food Chem; 2013 Oct; 61(40):9632-7. PubMed ID: 24028689
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Molecular Mechanism of Curcumin and Its Analogs as Multifunctional Compounds against Pancreatic Cancer.
    Huang Q; Zhang Y; Zheng Y; Yang H; Yang Y; Mo Y; Li L; Zhang H
    Nutr Cancer; 2022; 74(9):3096-3108. PubMed ID: 35583289
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Shedding light on curcumin stability.
    Appendino G; Allegrini P; de Combarieu E; Novicelli F; Ramaschi G; Sardone N
    Fitoterapia; 2022 Jan; 156():105084. PubMed ID: 34785239
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Increasing the solubility of the nutraceutical curcumin by heat and inhibition of oxidative modification.
    Kurien BT; Scofield RH
    Mol Nutr Food Res; 2009 Feb; 53(2):308. PubMed ID: 19198014
    [No Abstract]   [Full Text] [Related]  

  • 60. Plasma proteins interaction with curcumin nanoparticles: implications in cancer therapeutics.
    Yallapu MM; Ebeling MC; Jaggi M; Chauhan SC
    Curr Drug Metab; 2013 May; 14(4):504-15. PubMed ID: 23566382
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.